Clinical trials for Liver and bile duct cancer

133 currently recruiting clinical trials
Phase 2 Liver and bile duct cancer #NCT05265208 #2024-516683-29-00
Intrahepatic cholangiocarcinoma Localized None Systemic Treatment-Naive
Chemotherapy Radiotherapy
Centre Eugene Marquis (Rennes), CHU - Haut-Lévêque - Bordeaux (Pessac), Gustave Roussy (Villejuif), Hôpital Beaujon (Clichy)
Centre Eugène Marquis
Phase 2 Liver and bile duct cancer #NCT04727307 #2024-519113-59-00
Hepatocellular carcinoma Localized Unhealthy A None Systemic Treatment-Naive
Surgery Transplant
Hôpital Jean-Verdier AP-HP (Bondy), Centre Hospitalier de Perpignan (Perpignan), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy), Centre Hospitalier Universitaire de Lille (Lille), Hôpital Beaujon (Clichy) (and 9 more...)
CHU de Montpellier
Phase 2 Liver and bile duct cancer #NCT06330064 #2023-509632-26-00
Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A B C 1 Immunotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Eugene Marquis (Rennes), Gustave Roussy (Villejuif), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris) (and 5 more...)
Daiichi Sankyo
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05503797 #2024-513578-23-00
Locally Advanced Metastatic BRAF 1 2 3 or more
KRAS G12C KRAS non G12C NRAS HRAS Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 2 more...)
Fore Biotherapeutics
Phase 2 Liver and bile duct cancer #NCT05528952
Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A None Systemic Treatment-Naive
Immunotherapy
Site du Mittan - Hôpital Nord Franche-Comté (Montbéliard), Ghrmsa - Hôpital Emile Muller (Mulhouse), Centre Hospitalier William Morey (Chalon-sur-Saône), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Mutualiste Montsouris (Paris) (and 6 more...)
CHU de Besançon
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT06475352
Locally Advanced Metastatic None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Centre Hospitalier de la Côte Basque (Bayonne) (and 30 more...)
UNICANCER
Phase 2 Liver and bile duct cancer #NCT06045975
Hepatocellular carcinoma Localized Unhealthy A A None Systemic Treatment-Naive
Transplant Immunotherapy
Hôpital Beaujon (Clichy), Hôpital Avicenne - AP-HP (Bobigny)
Assistance Publique - Hôpitaux de Paris
Phase 1 / Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST #NCT03093116 #2024-512606-25-00
Groupe 5
Metastatic NTRK-1/2/3 1 2 3 or more Immunotherapy Chemotherapy
Systemic Treatment-Naive Targeted therapy
Gustave Roussy (Villejuif), Centre Antoine Lacassagne (Nice), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT05768139 #2023-000442-41
Cohortes monothérapie (partie 1)
Oral cavity Nasopharynx Oropharynx Hypopharynx Larynx Nasal cavities and sinuses Squamous cell carcinoma HR Positive Locally Advanced Metastatic PIK3CA 1 2 3 or more
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), IUCT Oncopôle (Toulouse)
Eli Lilly et compagnie
Phase 1 / Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST #NCT03093116 #2024-512606-25-00
Groupe 6
Metastatic NTRK-1/2/3 1 2 3 or more Targeted therapy
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Centre Antoine Lacassagne (Nice), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Turning Point Therapeutics, Inc.